Literature DB >> 17188850

Recombination and expression of classical swine fever virus (CSFV) structural protein E2 gene in Chlamydomonas reinhardtii chroloplasts.

Dong-Mei He1, Kai-Xian Qian, Gui-Fang Shen, Zhi-Fang Zhang, Yi-Nü Li, Zhong-Liang Su, Hong-Bo Shao.   

Abstract

The expression of classical swine fever virus (CSFV) structural protein E2 in different vectors, which has been shown to carry critical epitopes, has been established. Here, we reported a Chlamydomonas reinhardtii chloroplast expression vector, P64E2, containing classical swine fever virus structural protein E2 gene, which was constructed and transferred to C. reinhardtii by biolistic bombardment method. The transformants were identified by PCR, Southern blotting, Western blotting after selecting on resistant media. ELISA quantification assay showed that the expressed E2 protein accumulated up to 1.5-2% of the total soluble protein. The results of the study on the immunological activity indicated that the protein E2 expressed in C. reinhardtii chloroplasts could elicit animal bodies to produce antibodies against protein E2.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17188850     DOI: 10.1016/j.colsurfb.2006.10.042

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  21 in total

1.  Haematococcus as a promising cell factory to produce recombinant pharmaceutical proteins.

Authors:  Amir Ata Saei; Parisa Ghanbari; Abolfazl Barzegari
Journal:  Mol Biol Rep       Date:  2012-06-26       Impact factor: 2.316

Review 2.  Photosynthetic biomanufacturing in green algae; production of recombinant proteins for industrial, nutritional, and medical uses.

Authors:  Beth A Rasala; Stephen P Mayfield
Journal:  Photosynth Res       Date:  2014-03-22       Impact factor: 3.573

Review 3.  Manipulation of the microalgal chloroplast by genetic engineering for biotechnological utilization as a green biofactory.

Authors:  Yong Min Kwon; Kyung Woo Kim; Tae-Young Choi; Sun Young Kim; Jaoon Young Hwan Kim
Journal:  World J Microbiol Biotechnol       Date:  2018-11-26       Impact factor: 3.312

Review 4.  Non-conventional expression systems for the production of vaccine proteins and immunotherapeutic molecules.

Authors:  Isabelle Legastelois; Sophie Buffin; Isabelle Peubez; Charlotte Mignon; Régis Sodoyer; Bettina Werle
Journal:  Hum Vaccin Immunother       Date:  2016-12-01       Impact factor: 3.452

Review 5.  Chlamydomonas reinhardtii as a viable platform for the production of recombinant proteins: current status and perspectives.

Authors:  Sergio Rosales-Mendoza; Luz María Teresita Paz-Maldonado; Ruth Elena Soria-Guerra
Journal:  Plant Cell Rep       Date:  2011-11-12       Impact factor: 4.570

Review 6.  The green vaccine: A global strategy to combat infectious and autoimmune diseases.

Authors:  Abdoreza Davoodi-Semiromi; Nalapalli Samson; Henry Daniell
Journal:  Hum Vaccin       Date:  2009-07-23

7.  Robust expression and secretion of Xylanase1 in Chlamydomonas reinhardtii by fusion to a selection gene and processing with the FMDV 2A peptide.

Authors:  Beth A Rasala; Philip A Lee; Zhouxin Shen; Steven P Briggs; Michael Mendez; Stephen P Mayfield
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

Review 8.  Micro-algae come of age as a platform for recombinant protein production.

Authors:  Elizabeth Specht; Shigeki Miyake-Stoner; Stephen Mayfield
Journal:  Biotechnol Lett       Date:  2010-06-17       Impact factor: 2.461

Review 9.  Harnessing the Algal Chloroplast for Heterologous Protein Production.

Authors:  Edoardo Andrea Cutolo; Giulia Mandalà; Luca Dall'Osto; Roberto Bassi
Journal:  Microorganisms       Date:  2022-03-30

10.  A novel expression platform for the production of diabetes-associated autoantigen human glutamic acid decarboxylase (hGAD65).

Authors:  Xiaofeng Wang; Martin Brandsma; Reynald Tremblay; Denis Maxwell; Anthony M Jevnikar; Norm Huner; Shengwu Ma
Journal:  BMC Biotechnol       Date:  2008-11-17       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.